Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ZAV
|
|||
| Former ID |
DIB011339
|
|||
| Drug Name |
RG-8803
|
|||
| Synonyms |
Angiogenesis inhibitors, Repligen; BFGF inhibitors, Repligen; RG-8803B11; RGEN-1009; VEGF inhibitors, Repligen; 8803B11
Click to Show/Hide
|
|||
| Indication | Diabetic retinopathy [ICD-11: 9B71.0; ICD-10: H36.0; ICD-9: 250.5] | Terminated | [1] | |
| Company |
Repligen Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011158) | |||
| REF 2 | US patent application no. 2010,0278,784, Methods and compositions for treating skin conditions. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.